Aslanกำลังโหลดกราฟ…
Novartis บริษัทยาสวิส คู่แข่งของ Roche ครอบคลุม specialty pharma, oncology, gene therapy (Zolgensma)
Key Statistics — NOVN
Intraday
Open
112.54
Prev. Close
113.00
Volume
2.86M
Fundamentals
Market Cap
216.61B
P/E Ratio
20.79×
Dividend Yield
4.13%
ตัวเลขสำคัญ
รายได้รวม56.58B
EBITDA22.92B
EPS5.4600
P/E20.79×
P/BV7.15×
EV/EBITDA11.22×
ROE34.9%
ROA10.5%
Gross Margin75.6%
Net Margin23.9%
จำนวนหุ้น1.91B
Current Ratio0.85
D/E Ratio120.7%
Div. Yield4.13%
Ex-Div Date10 Mar 2026
Earnings Date21 Jul 2026
Price data is provided for informational purposes only and does not constitute investment advice. Quotes may be delayed. Aslan Finance is not responsible for any trading decisions made on the basis of information displayed on this page.